Detalhe da pesquisa
1.
Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622.
Breast Cancer Res Treat
; 159(1): 87-95, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27475087
2.
A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor-positive Breast Cancer, SWOG S1222.
Clin Cancer Res
; 28(4): 611-617, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34844978
3.
A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408.
Clin Cancer Res
; 26(17): 4468-4477, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32532790
4.
Concurrent bevacizumab with a sequential regimen of doxorubicin and cyclophosphamide followed by docetaxel and capecitabine as neoadjuvant therapy for HER2- locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group.
Clin Breast Cancer
; 11(4): 228-34, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21684812